Gentle, doctor

If it feels like medicine is changing faster than ever, you’re not wrong. What’s different now is why it’s changing. The system is finally — slowly — acknowledging that older patients aren’t just bigger versions of younger ones. They have different goals, different tolerances, and a much stronger interest in quality of life than heroic interventions.

Today’s Medical Monday stories sit right at that crossroads: smarter care, gentler care, and more honest conversations — especially for people over 60 who’ve already learned that “more” isn’t always better.

Let me start with the unsettling part: drug shortages are no longer rare, temporary hiccups. They’re becoming a feature of the healthcare system — and seniors are feeling it first and hardest.

Over the past two years, the Wall Street Journal and New York Times have reported on persistent shortages of common generics, injectable drugs, cancer therapies, antibiotics, and even basic saline solutions. These aren’t exotic medications. They’re the boring, workhorse drugs that keep blood pressure steady, infections controlled, and chronic conditions manageable.

And when they vanish? It’s older patients who scramble.

Here’s the counterintuitive truth: many of the drugs in shortest supply are too inexpensive to be attractive.

Most generics used by seniors are off-patent, low-margin products. Manufacturers operate on razor-thin profits, often producing drugs overseas in highly consolidated factories. When one plant shuts down due to quality issues, raw material shortages, or regulatory problems, there’s often no backup.

The New York Times has detailed how the U.S. relies on a fragile global supply chain, with limited incentives for companies to keep making older injectables or hospital staples. As one executive told the WSJ: “There’s no financial reward for redundancy.”

Translation: no cushion, no Plan B.

When your regular medication disappears, costs rise quietly.

You may be switched to a brand-name alternative, face higher copays, or need multiple appointments to adjust dosing. Medicare Part D plans don’t always cover substitutes at the same rate, and temporary changes can become permanent expenses.

Hospitals and clinics also feel the squeeze, passing costs downstream. The Journal has reported that shortages drive up healthcare spending not through price hikes — but through inefficiency, substitutions, and delays.

In other words, shortages don’t just disrupt care. They quietly drain wallets.

Seniors take more medications. They rely more on injectables and infusions. And many can’t easily tolerate substitutions.

A missed dose isn’t just inconvenient — it can mean hospitalization, confusion, or destabilization. As JAMA and NEJM have noted, medication continuity matters more as we age, because our bodies have less margin for error.

This is the practical part worth saving.

Here’s what actually helps:

The Wall Street Journal has shown that patients who plan ahead fare far better than those reacting at the counter.

Drug shortages aren’t your fault — but preparation is now part of staying healthy. A little planning, a few conversations, and some paperwork can mean the difference between a minor annoyance and a major disruption.

Your inbox is flooded with newsletters. Your feed is chaos. Somewhere in that noise are the insights that could transform your work—but who has time to find them?

The Deep View solves this. We read everything, analyze what matters, and deliver only the intelligence you need. No duplicate stories, no filler content, no wasted time. Just the essential AI developments that impact your industry, explained clearly and concisely.

Replace hours of scattered reading with five focused minutes. While others scramble to keep up, you'll stay ahead of developments that matter. 600,000+ professionals at top companies have already made this switch.

Join them today, for free.

Confession: once you hit 70, you stop being “a patient” and become… a business model.

Health systems are rapidly redesigning care around people in their 70s, 80s, and 90s—because that’s where the need is, the risk is, and (brace yourself) the spending lives. Programs branded “Age-Friendly,” geriatric-focused emergency departments, medication reviews, mobility-first rehab—this is medicine finally admitting a simple truth: older bodies are more complex, and complexity is expensive.

The best version of this shift is genuinely beautiful: fewer falls, fewer delirium spirals after hospital stays, fewer medication pileups that leave people foggy and exhausted. The worst version? A maze of “care pathways” that feels like you’re being processed like luggage at Pearson—tagged, scanned, and sent to a mystery carousel.

Per-capita healthcare spending rises steadily with age, and health systems feel that pressure every single day. So they’re standardizing “what good looks like” for older adults—partly to improve outcomes, partly because predictable care reduces costly complications. Frameworks like the Age-Friendly Health Systems “4Ms” (What Matters, Medication, Mentation, Mobility) are becoming a default playbook, because they force clinicians to focus on function and goals—not just lab numbers.

And yes, there’s an uncomfortable truth here: in many payment models, “risk” gets priced. Plans and systems that manage older patients well can be rewarded; those that don’t get swamped. Translation: you are valuable, and you deserve care that treats you like a person—not a margin.

Good news: when a clinic is built for older adults, you often get more time, clearer explanations, and fewer “drive-by” decisions. Less-good news: you may be routed into specialized lanes—great when they’re staffed, maddening when they’re not. Think faster triage, but longer scheduling; more check-ins, but more forms. You may also be offered care at home more often, because home-based models can be cheaper with equal-or-better outcomes in the right situations.

The trick is making sure that reinvention is designed around you, not just the spreadsheet. Ask better questions, bring your list, and don’t be shy about saying: “Slow down—I want to understand.”

Bradley Cooper (1975) — Actor, director, and proof that a good night’s sleep is the best anti-aging strategy Hollywood refuses to talk about. He’s spoken openly about sobriety and mental health, making him an accidental role model for aging with intention. Learn more

Hayao Miyazaki (1941) — Legendary animator who keeps “retiring” and then returning to work because, as he’s said, creativity doesn’t respect official timelines. Read more

Umberto Eco (1932) — Philosopher and novelist who once argued that memory is the most important human faculty — a belief modern neuroscience increasingly agrees with. More here

Robert Duvall (1931) — Still acting into his 90s, quietly reminding us that purpose is one of the strongest longevity drugs available. Profile

Let me say something that would’ve sounded radical even ten years ago: sometimes the best medical decision is… doing less.

Not ignoring symptoms. Not skipping care. But choosing restraint over reflex. Thoughtfulness over escalation. And quality of life over sheer survival math.

This shift has a name now — often called gentler medicine — and it’s one of the most important (and underreported) changes happening in healthcare for people over 65.

New clinical guidelines, especially in geriatrics, oncology, cardiology, and end-of-life care, are increasingly asking a once-taboo question: Does this intervention meaningfully improve this person’s life?

Major journals like The New England Journal of Medicine and JAMA have published research showing that aggressive treatments in older adults can sometimes lead to worse outcomes — more hospitalizations, confusion, falls, and functional decline — without extending life in a meaningful way. The Wall Street Journal has covered how doctors are rethinking chemo intensity, surgery timing, and even routine screenings for older patients with multiple conditions.

In plain English: medicine is finally admitting that a 75-year-old body is not a 45-year-old body with more wrinkles.

Here’s the uncomfortable truth: more medicine is often more expensive — and not always more effective.

Repeated scans, invasive procedures, prolonged hospital stays, and aggressive drug regimens drive up lifetime healthcare costs fast. Studies cited by MedPAC and reported on by the New York Times show that patients who opt for less aggressive care near the end of life often experience lower costs and better comfort.

This isn’t about rationing care. It’s about aligning care with actual goals — staying independent, clear-headed, mobile, and at home as long as possible.

This is the part I wish someone had explained to our parents.

Gentler medicine doesn’t mean giving up. It means choosing wisely.

Here’s what that looks like in real life:

Doctors are increasingly trained to ask: What matters to you? not just What can we do to you?

Gentler medicine isn’t about settling for less. It’s about choosing better. Better days. Better clarity. Better conversations. And the growing realization that the most advanced care sometimes knows when to step back.

Let me start with the good news: we know more about the aging brain today than at any point in human history. The less comfortable news? That knowledge has triggered a gold rush.

From blood tests that claim to spot Alzheimer’s years early, to apps, supplements, scans, and “brain gyms” promising peace of mind, cognitive health has quietly become one of the most lucrative frontiers in medicine. According to reporting in The Wall Street Journal and The New York Times, investors have poured billions into early detection tools — some promising, some premature, some very good at marketing fear.

There are real breakthroughs. Researchers can now detect biological markers of Alzheimer’s and other neurodegenerative diseases earlier than ever before. Blood-based biomarkers, advanced PET imaging, and refined cognitive assessments are changing how doctors understand risk.

But here’s the part the headlines often skip: early detection does not always mean early treatment. As The New England Journal of Medicine and JAMA have both pointed out, knowing you’re “at risk” years in advance doesn’t necessarily change outcomes — especially when treatments are limited or modestly effective.

In other words, information is powerful… but only when it leads somewhere useful.

Brain health is now a trillion-dollar market when you include diagnostics, drugs, supplements, digital therapeutics, caregiving tools, and long-term care planning. Pharmaceutical companies are racing to develop disease-modifying drugs. Tech firms are selling cognitive tracking platforms. Startups are bundling tests, coaching, and dashboards that feel reassuring — whether or not they improve health.

The WSJ has reported on how insurers, employers, and even retirement communities are beginning to market “brain health programs” as a premium feature. Some are evidence-based. Some are… vibes.

The business model often looks like this: measure anxiety, sell reassurance, repeat annually.

This is where being a savvy older adult matters more than ever.

Here’s a quick reality check you can keep handy:

Doctors quoted in The New York Times emphasize that exercise, sleep, blood pressure control, hearing care, and social engagement still outperform most high-tech solutions when it comes to preserving cognition.

Your brain deserves care, not constant monitoring for profit. Invest in what strengthens daily life. Be curious, but skeptical. And remember: the most powerful brain-health tools are still remarkably unglamorous — and often free.

1925 — Nellie Tayloe Ross becomes the first woman governor in the U.S., paving the way for women in public health leadership decades before it was fashionable. History

1957 — The first successful use of a heart-lung machine in open-heart surgery is reported, changing cardiac care forever — and making today’s less-invasive procedures possible. NIH archive

1981 — Scientists identify the first cases of what would later be known as AIDS, marking the beginning of one of medicine’s most humbling learning curves. CDC history

Let me tell you something mildly infuriating: most of what you pay for healthcare isn’t determined by your doctor. Or your hospital. Or even the medication itself. It’s determined by the middlemen quietly standing between them — insurers, pharmacy benefit managers (PBMs), and sprawling hospital systems that negotiate prices behind closed doors.

The good news? Those doors are starting to crack open.

Over the past year, the Wall Street Journal, New York Times, and Bloomberg have all reported on mounting pressure — from regulators, employers, and patients — to explain why the same drug or procedure can cost wildly different amounts depending on who’s paying, who’s billing, and who’s skimming a fee along the way.

In theory, middlemen are supposed to lower costs by negotiating better deals. In reality, the system has grown so complex that savings often get lost before they ever reach patients.

PBMs, for example, decide which drugs make it onto insurance formularies and how much pharmacies get reimbursed. Insurers bundle services into Medicare Advantage plans with glossy perks — while quietly restricting access. Hospital systems consolidate, gain negotiating power, and charge more because… they can.

The New York Times has documented how these layers add opacity, not clarity. Prices go up, explanations get fuzzier, and patients are left squinting at bills like they’re written in another language.

Here’s where it hits home if you’re over 65.

Medicare Advantage plans often promise lower premiums and extra benefits — dental, vision, gym memberships — but the Journal has shown how some plans compensate by narrowing networks, requiring prior authorizations, or denying coverage for certain services.

On the prescription side, PBMs can earn revenue through spread pricing (charging insurers more than they reimburse pharmacies) and manufacturer rebates that don’t always lower what you pay at the counter. The result? Higher out-of-pocket costs, even when the “list price” hasn’t changed much.

You don’t see these markups directly. You feel them.

Here’s a short, practical checklist worth keeping:

The Wall Street Journal has repeatedly shown that small questions can lead to big savings — especially for seniors who use healthcare frequently.

You don’t need to overhaul your healthcare to protect your wallet. You just need to know where the money leaks happen. The war on medical middlemen isn’t about blame — it’s about transparency. And transparency, finally, is on your side.

Let’s start by clearing the air: “exit planning” is not a morbid euphemism cooked up by hospital accountants. It’s a long-overdue shift in medicine toward honesty, agency, and dignity — especially for people over 65.

Medical schools, large health systems, and specialty societies are now actively training doctors to initiate end-of-life conversations earlier, calmer, and without panic. According to reporting in the New York Times and Wall Street Journal, this change is being driven by two forces: overwhelming evidence that patients want more control — and the uncomfortable reality that the last months of life are often the most expensive and least humane.

For decades, doctors were taught to avoid “giving up.” Talking about death felt like failure. But modern training now emphasizes something different: aligning care with a patient’s values.

Medical schools are incorporating structured conversations about goals of care. Hospitals are embedding palliative care teams earlier. And clinicians are being encouraged to ask better questions — not just Can we treat this? but Should we? and At what cost to the person living it?

The New England Journal of Medicine has published multiple studies showing that patients who engage in advance care planning often experience less aggressive care, better symptom control, and higher satisfaction — without shorter lives.

Here’s the part that makes policymakers sweat.

A disproportionate share of healthcare spending occurs in the final year of life — often driven by ICU stays, repeated hospitalizations, and invasive procedures that may extend life briefly, but frequently reduce its quality.

The Wall Street Journal and Kaiser Family Foundation have both reported that many families are shocked to learn how quickly costs mount when preferences aren’t documented. Medicare covers a lot — but not everything. And emotional decision-making under pressure is rarely a money-saving strategy.

Exit planning isn’t about spending less. It’s about spending intentionally.

This is where the relief comes in.

Done well, exit planning doesn’t lock you into decisions. It gives you flexibility, clarity, and leverage — while you’re calm and healthy.

Here’s what doctors increasingly recommend having in place:

As the New York Times has noted, families who plan early report less guilt, fewer conflicts, and greater peace — even during grief.

Exit planning isn’t about death — it’s about control. The earlier you talk, the more choices you keep. And the greatest gift you can give your family isn’t instructions for everything… it’s clarity when things get hard.

What part of the human body uses more energy per minute than any other organ — even when you’re completely at rest?